Xinxiang Jingquan Biotechnology Co., Ltd. (hereinafter referred to as "Jingquan Biotechnology") has successfully completed rigorous scientific evaluation and obtained Self-GRAS status for its core product L-α-Glycerylphosphorylcholine (L-α-GPC) in compliance with the Generally Recognized As Safe (GRAS) criteria set by the U.S. Food and Drug Administration (FDA).

This milestone indicates that the L-α-GPC manufactured by Jingquan Biotechnology meets internationally authoritative standards in terms of quality, safety and application scope, laying a solid foundation for its entry into the global markets of high-end foods, dietary supplements and foods for special medical purposes.

GRAS is one of the safety grade certifications issued by the U.S. Food and Drug Administration (FDA) for food additives and dietary ingredients. The Self-GRAS scientific evaluation completed by Jingquan Biotechnology this time is based on globally recognized scientific standards and extensive published research data, and confirmed after comprehensive and rigorous review by an independent third-party expert panel. This certification verifies that L-α-GPC is safe under specified usage conditions and can be applied in various dietary supplements and foods.

L-α-Glycerylphosphorylcholine (L-α-GPC) is a choline compound naturally present in the human body and a key component of brain nerve cell membranes. The successful acquisition of this certification serves as powerful validation of the safety of Jingquan Biotechnology’s products, and further demonstrates the company’s strong comprehensive strengths in raw material R&D, quality control and international compliance. It means our L-α-GPC raw materials have obtained a "passport" to enter the U.S. market and numerous international markets that recognize FDA standards, enabling us to supply global clients with safe, reliable, compliant and high-quality raw material options.